The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a pill.

WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus on ...

--The company currently guides for 16%-24% sales growth at constant exchange rates and for 19%-27% operating profit growth. "With the continued weak trends in the U.S. continuing into 2Q, we now ...

DEAR PEOPLE’S PHARMACY: I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock. I lost 17 pounds and my A1C ...

Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

In the past two weeks, as prescription volumes have remained sluggish, analysts cut first-quarter sales estimates for Wegovy by about 5%. - Shelby Knowles/Bloomberg News Novo Nordisk sparked the ...

Prescription data from health-analytics company Iqvia, tracked by Wall Street analysts, shows U.S. demand for Ozempic and Wegovy has been largely flat to start the year, even as Eli Lilly’s ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.